Mannkind Corporation rises 2.29% premarket due to Tempus and United Therapeutics' collaboration in PAH treatments.

Wednesday, Jun 26, 2024 8:39 am ET1min read
Mannkind Corporation rises 2.29% premarket due to Tempus and United Therapeutics' collaboration in PAH treatments.

Comments



Add a public comment...
No comments

No comments yet